Published in J Allergy Clin Immunol on December 04, 2009
Atopic dermatitis: a disease of altered skin barrier and immune dysregulation. Immunol Rev (2011) 2.62
Recent insights into atopic dermatitis and implications for management of infectious complications. J Allergy Clin Immunol (2010) 2.20
Staphylococcus δ-toxin induces allergic skin disease by activating mast cells. Nature (2013) 1.56
Encoding a superantigen by Staphylococcus aureus does not affect clinical characteristics of infected atopic dermatitis lesions. Br J Dermatol (2010) 1.40
Extracellular vesicles derived from Staphylococcus aureus induce atopic dermatitis-like skin inflammation. Allergy (2010) 1.08
Microbial ecology of the skin in the era of metagenomics and molecular microbiology. Cold Spring Harb Perspect Med (2013) 1.07
Role of macrophages in the pathogenesis of atopic dermatitis. Mediators Inflamm (2013) 0.88
Regulation of T Cell Immunity in Atopic Dermatitis by Microbes: The Yin and Yang of Cutaneous Inflammation. Front Immunol (2015) 0.84
Staphlyococcus aureus phenol-soluble modulins stimulate the release of proinflammatory cytokines from keratinocytes and are required for induction of skin inflammation. Infect Immun (2015) 0.83
Epicutaneous exposure to staphylococcal superantigen enterotoxin B enhances allergic lung inflammation via an IL-17A dependent mechanism. PLoS One (2012) 0.81
Identification of staphylococcal protein A in infected atopic dermatitis lesions. J Invest Dermatol (2010) 0.80
The role of innate immune signaling in the pathogenesis of atopic dermatitis and consequences for treatments. Semin Immunopathol (2015) 0.79
Dendritic cells produce inflammatory cytokines in response to bacterial products from Staphylococcus aureus-infected atopic dermatitis lesions. Cell Immunol (2010) 0.78
Staphylococcus aureus lipoteichoic acid inhibits platelet activation and thrombus formation via the Paf receptor. J Infect Dis (2013) 0.77
Th2 Cytokines Suppress Lipoteichoic Acid-Induced Matrix Metalloproteinase Expression and Keratinocyte Migration in Response to Wounding. J Invest Dermatol (2015) 0.76
Altered cytokine production by dendritic cells from infants with atopic dermatitis. Clin Immunol (2010) 0.76
Toxic interaction between Th2 cytokines and Staphylococcus aureus in atopic dermatitis. J Invest Dermatol (2014) 0.76
NOD2 and TLR2 ligands trigger the activation of basophils and eosinophils by interacting with dermal fibroblasts in atopic dermatitis-like skin inflammation. Cell Mol Immunol (2015) 0.75
Treatment outcomes of secondarily impetiginized pediatric atopic dermatitis lesions and the role of oral antibiotics. Pediatr Dermatol (2011) 0.75
Cutaneous bacteria induce immunosuppression. Oncotarget (2015) 0.75
Endogenous antimicrobial peptides and skin infections in atopic dermatitis. N Engl J Med (2002) 9.01
Cutting edge: TLR2-deficient and MyD88-deficient mice are highly susceptible to Staphylococcus aureus infection. J Immunol (2000) 6.61
Atopic dermatitis. N Engl J Med (2008) 5.92
A new method for the quantitative investigation of cutaneous bacteria. J Invest Dermatol (1965) 5.71
Tlr4: central component of the sole mammalian LPS sensor. Curr Opin Immunol (2000) 4.32
The eczema area and severity index (EASI): assessment of reliability in atopic dermatitis. EASI Evaluator Group. Exp Dermatol (2001) 3.58
A novel polymorphism in the toll-like receptor 2 gene and its potential association with staphylococcal infection. Infect Immun (2000) 2.81
Recognition of Staphylococcus aureus by the innate immune system. Clin Microbiol Rev (2005) 2.50
Staphylococcus aureus in the lesions of atopic dermatitis. Br J Dermatol (1974) 2.43
Platelet-activating factor receptor and ADAM10 mediate responses to Staphylococcus aureus in epithelial cells. Nat Med (2002) 2.20
The role of toll-like receptors (TLRs) in bacteria-induced maturation of murine dendritic cells (DCS). Peptidoglycan and lipoteichoic acid are inducers of DC maturation and require TLR2. J Biol Chem (2001) 2.04
Toll-like receptor expression in human keratinocytes: nuclear factor kappaB controlled gene activation by Staphylococcus aureus is toll-like receptor 2 but not toll-like receptor 4 or platelet activating factor receptor dependent. J Invest Dermatol (2003) 1.69
The toll-like receptor 2 R753Q polymorphism defines a subgroup of patients with atopic dermatitis having severe phenotype. J Allergy Clin Immunol (2004) 1.35
Infection in atopic dermatitis. Curr Opin Pediatr (2003) 1.31
The role of microorganisms in atopic dermatitis. Clin Exp Immunol (2006) 1.31
Staphylococcal lipoteichoic acid inhibits delayed-type hypersensitivity reactions via the platelet-activating factor receptor. J Clin Invest (2005) 1.30
Staphylococcal toxins and protein A differentially induce cytotoxicity and release of tumor necrosis factor-alpha from human keratinocytes. J Invest Dermatol (1996) 1.23
Comparative study of staphylococci from the skin of atopic dermatitis patients and from healthy subjects. Int J Dermatol (1999) 1.14
Scratching the surface: towards understanding the pathogenesis of atopic dermatitis. Crit Rev Immunol (2008) 1.10
Atopic dermatitis. J Am Acad Dermatol (2005) 1.07
Augmentation of UVB radiation-mediated early gene expression by the epidermal platelet-activating factor receptor. J Invest Dermatol (2007) 1.06
Role of bacterial superantigens in atopic dermatitis : implications for future therapeutic strategies. Am J Clin Dermatol (2006) 1.05
Assessment of a contact-plate sampling technique and subsequent quantitative bacterial studies in atopic dermatitis. Br J Dermatol (1990) 1.04
Epidemiological characteristics of methicillin-resistant Staphylococcus aureus isolates from children with eczematous atopic dermatitis lesions. J Clin Microbiol (2008) 1.04
The Toll-like receptor 2 R753Q mutation modifies cytokine production and Toll-like receptor expression in atopic dermatitis. J Allergy Clin Immunol (2008) 1.03
Effects of staphylococci on cytokine production from human keratinocytes. Br J Dermatol (2003) 0.97
Skin colonization of Staphylococcus aureus in atopic dermatitis patients seen at the National Skin Centre, Singapore. Int J Dermatol (1997) 0.87
Augmentation of staphylococcal alpha-toxin signaling by the epidermal platelet-activating factor receptor. J Invest Dermatol (2003) 0.86
Lipoteichoic acid from Staphylococcus aureus induces Th2-prone dermatitis in mice sensitized percutaneously with an allergen. Clin Exp Allergy (2002) 0.85
Tumor necrosis factor production by human granulocytes. Int Arch Allergy Appl Immunol (1991) 0.85
Cell wall components of Staphylococcus aureus induce interleukin-5 production in patients with atopic dermatitis. J Interferon Cytokine Res (2000) 0.79
Lipoteichoic acid from Staphylococcus aureus enhances allergen-specific immunoglobulin E production in mice. Clin Exp Allergy (2003) 0.78
Stat3 and Stat4 direct development of IL-17-secreting Th cells. J Immunol (2007) 5.16
Electrocardiographic abnormalities and sudden death in myotonic dystrophy type 1. N Engl J Med (2008) 4.65
The transcription factor PU.1 is required for the development of IL-9-producing T cells and allergic inflammation. Nat Immunol (2010) 3.97
MAP kinase phosphatase 1 controls innate immune responses and suppresses endotoxic shock. J Exp Med (2005) 3.37
IL-6 controls Th17 immunity in vivo by inhibiting the conversion of conventional T cells into Foxp3+ regulatory T cells. Proc Natl Acad Sci U S A (2008) 3.04
Relationship between daily dose of oral medications and idiosyncratic drug-induced liver injury: search for signals. Hepatology (2008) 2.66
Fragmented QRS on a 12-lead ECG: a predictor of mortality and cardiac events in patients with coronary artery disease. Heart Rhythm (2007) 2.37
T-bet is a critical determinant in the instability of the IL-17-secreting T-helper phenotype. Blood (2006) 2.34
A brief history of IL-9. J Immunol (2011) 2.27
Accuracy and yield of ICD-9 codes for identifying children with ischemic stroke. Neurology (2006) 2.25
The aortopathy of bicuspid aortic valve disease has distinctive patterns and usually involves the transverse aortic arch. J Thorac Cardiovasc Surg (2008) 2.20
IL-23 promotes maintenance but not commitment to the Th17 lineage. J Immunol (2008) 2.06
Signal transducer and activator of transcription 4 is required for the transcription factor T-bet to promote T helper 1 cell-fate determination. Immunity (2008) 2.04
Interferon regulatory factor 4 sustains CD8(+) T cell expansion and effector differentiation. Immunity (2013) 2.03
The transcription factor STAT3 is required for T helper 2 cell development. Immunity (2011) 2.03
Out-of-hemodialysis-unit blood pressure is a superior determinant of left ventricular hypertrophy. Hypertension (2005) 1.98
Prospective study of infantile hemangiomas: demographic, prenatal, and perinatal characteristics. J Pediatr (2007) 1.96
Growth characteristics of infantile hemangiomas: implications for management. Pediatrics (2008) 1.95
PU.1 expression delineates heterogeneity in primary Th2 cells. Immunity (2005) 1.93
Proinflammatory cytokine signaling required for the generation of natural killer cell memory. J Exp Med (2012) 1.89
Transcriptional regulation by STAT6. Immunol Res (2011) 1.81
C-reactive protein, arterial endothelial activation, and development of transplant coronary artery disease: a prospective study. Lancet (2002) 1.80
Human endogenous retrovirus K (HML-2) elements in the plasma of people with lymphoma and breast cancer. J Virol (2008) 1.79
Infantile hemangiomas: current knowledge, future directions. Proceedings of a research workshop on infantile hemangiomas, April 7-9, 2005, Bethesda, Maryland, USA. Pediatr Dermatol (2005) 1.77
Ethnic differences in renal responses to furosemide. Hypertension (2008) 1.74
Autonomous murine T-cell progenitor production in the extra-embryonic yolk sac before HSC emergence. Blood (2012) 1.72
Treatment of hyperglycemia in ischemic stroke (THIS): a randomized pilot trial. Stroke (2007) 1.70
Barriers to insulin initiation: the translating research into action for diabetes insulin starts project. Diabetes Care (2010) 1.66
Using change in the National Institutes of Health Stroke Scale to measure treatment effect in acute stroke trials. Stroke (2006) 1.60
STAT6-dependent regulation of Th9 development. J Immunol (2011) 1.60
Interleukin (IL)-4 inhibits IL-10 to promote IL-12 production by dendritic cells. J Exp Med (2005) 1.59
Variability in the upper limit of normal for serum alanine aminotransferase levels: a statewide study. Hepatology (2009) 1.59
Rap1a null mice have altered myeloid cell functions suggesting distinct roles for the closely related Rap1a and 1b proteins. J Immunol (2007) 1.56
IFN regulatory factor 4 regulates the expression of a subset of Th2 cytokines. J Immunol (2009) 1.51
IL-4 regulates skin homeostasis and the predisposition toward allergic skin inflammation. J Immunol (2010) 1.49
Effect of advanced access scheduling on processes and intermediate outcomes of diabetes care and utilization. J Gen Intern Med (2009) 1.47
Fibroblast senescence and squamous cell carcinoma: how wounding therapies could be protective. Dermatol Surg (2013) 1.44
Interleukin-9 is required for allergic airway inflammation mediated by the cytokine TSLP. Immunity (2013) 1.43
Expression of a constitutively active Stat6 in vivo alters lymphocyte homeostasis with distinct effects in T and B cells. J Immunol (2003) 1.42
Detection of HERV-K(HML-2) viral RNA in plasma of HIV type 1-infected individuals. AIDS Res Hum Retroviruses (2006) 1.40
A double-blind randomized crossover trial of two loop diuretics in chronic kidney disease. Kidney Int (2003) 1.40
Distinct requirements for the naturally occurring splice forms Stat4alpha and Stat4beta in IL-12 responses. EMBO J (2003) 1.39
Stat4 limits DNA methyltransferase recruitment and DNA methylation of the IL-18Ralpha gene during Th1 differentiation. EMBO J (2007) 1.34
Stat6-deficient mice develop airway hyperresponsiveness and peribronchial fibrosis during chronic fungal asthma. Am J Pathol (2002) 1.34
Vaccinia virus infection modulates the hematopoietic cell compartments in the bone marrow. Stem Cells (2008) 1.33
Incidence, risk factors, and treatment patterns for deep venous thrombosis in hospitalized children: an increasing population at risk. J Vasc Surg (2008) 1.32
Staphylococcal lipoteichoic acid inhibits delayed-type hypersensitivity reactions via the platelet-activating factor receptor. J Clin Invest (2005) 1.30
Lithium protects ethanol-induced neuronal apoptosis. Biochem Biophys Res Commun (2006) 1.29
Characterization of human endogenous retroviral elements in the blood of HIV-1-infected individuals. J Virol (2011) 1.26
PU.1 regulates TCR expression by modulating GATA-3 activity. J Immunol (2009) 1.20
Ultraviolet B radiation generated platelet-activating factor receptor agonist formation involves EGF-R-mediated reactive oxygen species. J Immunol (2009) 1.19
BATF transgenic mice reveal a role for activator protein-1 in NKT cell development. J Immunol (2003) 1.19
Endothelial abnormalities in adolescents with type 1 diabetes: a biomarker for vascular sequelae? J Pediatr (2010) 1.18
Signal transducer and activator of transcription 4 limits the development of adaptive regulatory T cells. Immunology (2009) 1.16
Th9 cell development requires a BATF-regulated transcriptional network. J Clin Invest (2013) 1.15
Multicenter prospective study of ulcerated hemangiomas. J Pediatr (2007) 1.15
Thymic selection pathway regulates the effector function of CD4 T cells. J Exp Med (2007) 1.15
Bcl6 controls the Th2 inflammatory activity of regulatory T cells by repressing Gata3 function. J Immunol (2012) 1.13
Regulating Il9 transcription in T helper cells. Trends Immunol (2011) 1.12
IL-4 is a critical determinant in the generation of allergic inflammation initiated by a constitutively active Stat6. J Immunol (2008) 1.12
STAT4 is required for interleukin-12-induced chromatin remodeling of the CD25 locus. J Biol Chem (2003) 1.12
The symphony of the ninth: the development and function of Th9 cells. Curr Opin Immunol (2012) 1.12
UVB radiation-mediated inhibition of contact hypersensitivity reactions is dependent on the platelet-activating factor system. J Invest Dermatol (2008) 1.11
Improvement in HIV-related endothelial dysfunction using the anti-inflammatory agent salsalate: a pilot study. AIDS (2008) 1.11
Scratching the surface: towards understanding the pathogenesis of atopic dermatitis. Crit Rev Immunol (2008) 1.10
The role of constitutively active Stat6 in leukemia and lymphoma. Crit Rev Oncol Hematol (2005) 1.10
Expression of human endogenous retrovirus type K (HML-2) is activated by the Tat protein of HIV-1. J Virol (2012) 1.10
Predisposition to the development of IL-9-secreting T cells in atopic infants. J Allergy Clin Immunol (2011) 1.10
Gcn5 is required for PU.1-dependent IL-9 induction in Th9 cells. J Immunol (2012) 1.10
Temporal induction pattern of STAT4 target genes defines potential for Th1 lineage-specific programming. J Immunol (2009) 1.10
The change in blood pressure during pubertal growth. J Clin Endocrinol Metab (2004) 1.09
Enhanced production of IL-10 by dendritic cells deficient in CIITA. J Immunol (2005) 1.09
Cutting edge: induction of the antigen-processing enzyme IFN-gamma-inducible lysosomal thiol reductase in melanoma cells Is STAT1-dependent but CIITA-independent. J Immunol (2004) 1.09
Long-term effects of a community-based lifestyle intervention to prevent type 2 diabetes: the DEPLOY extension pilot study. Chronic Illn (2011) 1.08
Innate Stat3-mediated induction of the antimicrobial protein Reg3γ is required for host defense against MRSA pneumonia. J Exp Med (2013) 1.08
Th1 cells regulate hematopoietic progenitor cell homeostasis by production of oncostatin M. Immunity (2002) 1.08
NGSQC: cross-platform quality analysis pipeline for deep sequencing data. BMC Genomics (2010) 1.07
Impaired development of human Th1 cells in patients with deficient expression of STAT4. Blood (2009) 1.07
Evaluation of airway reactivity and immune characteristics as risk factors for wheezing early in life. J Allergy Clin Immunol (2010) 1.06
Augmentation of UVB radiation-mediated early gene expression by the epidermal platelet-activating factor receptor. J Invest Dermatol (2007) 1.06
Tc17 cells are capable of mediating immunity to vaccinia virus by acquisition of a cytotoxic phenotype. J Immunol (2010) 1.06
Oxidized glycerophosphocholines as biologically active mediators for ultraviolet radiation-mediated effects. Prostaglandins Other Lipid Mediat (2008) 1.06
The Bcl6 target gene microRNA-21 promotes Th2 differentiation by a T cell intrinsic pathway. Mol Immunol (2013) 1.06
The environmental stressor ultraviolet B radiation inhibits murine antitumor immunity through its ability to generate platelet-activating factor agonists. Carcinogenesis (2012) 1.05
Oral fish oil supplementation raises blood omega-3 levels and lowers C-reactive protein in haemodialysis patients--a pilot study. Nephrol Dial Transplant (2007) 1.04
Bruton's tyrosine kinase is required for TLR-induced IL-10 production. J Immunol (2006) 1.04
HIV infection reveals widespread expansion of novel centromeric human endogenous retroviruses. Genome Res (2013) 1.03
Twist1 regulates Ifng expression in Th1 cells by interfering with Runx3 function. J Immunol (2012) 1.02
A pilot randomized controlled trial of renal protection with pioglitazone in diabetic nephropathy. Kidney Int (2005) 1.01
Stat6 signaling suppresses VLA-4 expression by CD8+ T cells and limits their ability to infiltrate tumor lesions in vivo. J Immunol (2008) 1.01
Augmentation of chemotherapy-induced cytokine production by expression of the platelet-activating factor receptor in a human epithelial carcinoma cell line. J Immunol (2004) 1.00
Thymic stromal lymphopoietin interferes with airway tolerance by suppressing the generation of antigen-specific regulatory T cells. J Immunol (2011) 1.00
Vaccinia virus blocks Stat1-dependent and Stat1-independent gene expression induced by type I and type II interferons. J Interferon Cytokine Res (2008) 0.99
Cathepsin E: a novel target for regulation by class II transactivator. J Immunol (2004) 0.98